HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.

Abstract
Single and combination cytokines offer promise in some patients with advanced cancer. Many spontaneous and experimental cancers naturally express ligands for the lectin-like type-2 transmembrane stimulatory NKG2D immunoreceptor; however, the role this tumor recognition pathway plays in immunotherapy has not been explored to date. Here, we show that natural expression of NKG2D ligands on tumors provides an effective target for some cytokine-stimulated NK cells to recognize and suppress tumor metastases. In particular, interleukin (IL)-2 or IL-12 suppressed tumor metastases largely via NKG2D ligand recognition and perforin-mediated cytotoxicity. By contrast, IL-18 required tumor sensitivity to Fas ligand (FasL) and surprisingly did not depend on the NKG2D-NKG2D ligand pathway. A combination of IL-2 and IL-18 stimulated both perforin and FasL effector mechanisms with very potent effects. Cytokines that stimulated perforin-mediated cytotoxicity appeared relatively more effective against tumor metastases expressing NKG2D ligands. These findings indicate that a rational choice of cytokines can be made given the known sensitivity of tumor cells to perforin, FasL, and tumor necrosis factor-related apoptosis-inducing ligand and the NKG2D ligand status of tumor metastases.
AuthorsMark J Smyth, Jeremy Swann, Janice M Kelly, Erika Cretney, Wayne M Yokoyama, Andreas Diefenbach, Thomas J Sayers, Yoshihiro Hayakawa
JournalThe Journal of experimental medicine (J Exp Med) Vol. 200 Issue 10 Pg. 1325-35 (Nov 15 2004) ISSN: 0022-1007 [Print] United States
PMID15545356 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cytokines
  • Fas Ligand Protein
  • Fasl protein, mouse
  • Interleukin-18
  • Interleukin-2
  • Klrk1 protein, mouse
  • Ligands
  • Membrane Glycoproteins
  • Membrane Proteins
  • NK Cell Lectin-Like Receptor Subfamily K
  • Pore Forming Cytotoxic Proteins
  • Receptors, Immunologic
  • Receptors, Natural Killer Cell
  • Recombinant Proteins
  • perforin, mouse
  • Interleukin-12
Topics
  • Animals
  • Apoptosis (immunology)
  • Cytokines (immunology, metabolism, therapeutic use)
  • Fas Ligand Protein
  • Flow Cytometry
  • Immunotherapy (methods)
  • Interleukin-12 (immunology, metabolism)
  • Interleukin-18 (immunology, metabolism)
  • Interleukin-2 (immunology, metabolism)
  • Killer Cells, Natural (immunology, metabolism)
  • Ligands
  • Membrane Glycoproteins (immunology, metabolism)
  • Membrane Proteins (immunology, metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • NK Cell Lectin-Like Receptor Subfamily K
  • Neoplasm Metastasis (therapy)
  • Pore Forming Cytotoxic Proteins
  • Receptors, Immunologic (metabolism)
  • Receptors, Natural Killer Cell
  • Recombinant Proteins (immunology, metabolism, therapeutic use)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: